Impact of cardioselective beta-blockers on mortality in patients with chronic obstructive pulmonary disease and atherosclerosis.

@article{Gestel2008ImpactOC,
  title={Impact of cardioselective beta-blockers on mortality in patients with chronic obstructive pulmonary disease and atherosclerosis.},
  author={Yvette R B M van Gestel and Sanne Elisabeth Hoeks and Don D. Sin and Gijs M. J. M. Welten and O. Schouten and Han J Witteveen and Cihan Simsek and Henk J. Stam and Frans W Mertens and Jeroen J. Bax and Ron Theodoor van Domburg and Don Poldermans},
  journal={American journal of respiratory and critical care medicine},
  year={2008},
  volume={178 7},
  pages={695-700}
}
RATIONALE beta-Blocker use is associated with improved health outcomes in patients with cardiovascular disease. There is a general reluctance to prescribe beta-blockers in patients with chronic obstructive pulmonary disease (COPD) because they may worsen symptoms. OBJECTIVES We investigated the relationship between cardioselective beta-blockers and… CONTINUE READING